Table 1 Clinical characteristics of the study population at Intensive Care Unit admission.
Variable | no. (%) |
|---|---|
Gender | |
Male | 49 (69.1) |
Female | 22 (30.9) |
Acute physiology and chronic health evaluation (APACHE) II score | |
< 10 | 14 (19.7) |
10–14 | 26 (36.6) |
15–29 | 31 (43.7) |
Comorbidities | |
Diabetes mellitus | 17 (23.9) |
Asthma/chronic lung disease | 11 (15.5) |
Hypertension | 32 (45.0) |
Obesity | 38 (53.5) |
Chronic heart disease | 9 (12.6) |
Vascular disease | 7 (9.8) |
Cancer | 3 (4.2) |
Hematologic disease | 3 (4.2) |
Number of comorbidity conditions | |
One | 22 (31.0) |
Two or more | 32 (45.0) |
None | 17 (24.0) |
Oxygenation and ventilator support | |
Invasive mechanical ventilation | 63 (88.7) |
PiO2/FiO2 < 150 mmHg | 57 (80.2) |
Acute kidney disfunction | 17 (23.9) |
Antiviral or anti-inflammatory treatment | |
Remdesivir | 15 (21.1) |
Corticosteroids | 70 (98.5) |
Tocilizumab | 27 (38.0) |
